High ratios of CD8+ to Foxp3+ T-cells among TILs, for example, have been shown in a variety of solid tumors to be associated with favorable tumor characteristics, response to therapy and radiation, and improved patient survival [23–26]. This evidence concerns the gene CD8A and neoplasm.